Novo Nordisk will launch its hugely popular anti-obesity drug Wegovy in Japan on Feb. 22, its first launch in Asia, the company said on Thursday, even as it struggles to keep up with demand in existing markets. The Danish company has picked Japan as the sixth country in which to launch Wegovy despite obesity being a much smaller problem in the Asian country relative to the West. Most patients in Japan will pay 30% of medical expenses for Wegovy, in line with reimbursement for other drugs, said N
Norway
Denmark
Copenhagen
Køavn
Germany
Japan
United-kingdom
Japanese
Britain
Danish
Alexandra-hudson
Eli-lilly